A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
At present, there is no specific and effective antiviral therapy.In this study, an open,
prospective/retrospective, randomized controlled cohort study was designed to compare the
efficacy of three antiviral drugs in the treatment of 2019-nCoV pneumonia by studying the
efficacy of abidol hydrochloride, oseltamivir and lopinavir/ritonavir in the treatment of
2019-nCoV viral pneumonia, and to explore effective antiviral drugs for new coronavirus. To
provide reliable evidence-based medicine basis for the treatment of viral pneumonia caused by
new coronavirus infection.